Veracyte | VCYT - Ebitda



金融业
股票价格
USD
资产
USD 1.49B
现金及等价物
USD 299.52M
销售成本
USD 42.19M
流动资产
USD 574.78M
流动负债
USD 62.74M
债务
USD 39.33M
EBIT
USD 23.96M
EBITDA
USD 43.96M
员工
824
EPS每股收益
USD 0.54
股本和储备
USD 1.39B
销售毛利
USD 108.55M
债务利息支出
USD 2K
利息收入
USD 3.48M
贷款资金
USD 0
市值
USD 3.43B
净收入
USD 25.49M
营业费用
USD 126.36M
营业利润
USD 23.96M
普通股股本
USD 79.79M
PE价格收益
42.77
税前利润
USD 26.52M
销售收入
USD 150.32M
销售和管理费用
USD 55.71M
股票
USD 22.66M
贸易债权人
USD 8.02M
应收帐款人
USD 54.18M


Ebitda 更改 日
Agenus USD -10.11M 19.02M 2025-03
Agilent USD 577M 77M 2026-06
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
Bruker USD 143.2M 33.2M 2026-06
Heron Therapeutics USD -3.88M 5.63M 2024-09
Illumina USD 330M 80M 2026-06
Intrexon USD -24.7M 2.92M 2024-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Laboratory Of America USD 767.7M 162.1M 2026-06
Ligand Pharmaceuticals USD -14.3M 81.08M 2026-03
Myriad Genetics USD 14.3M 4M 2025-12
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Roche Holding CHF 13.43B 744M 2026-06
Siemens EUR 4.2B 644M 2026-06
Sonic Healthcare AUD 839.07M 51.09M 2024-12
Thermo Fisher Scientific USD 3.55B 845M 2026-06
Veracyte USD 43.96M 1.16M 2026-06
Waters USD 712M 545M 2026-06